Jacobs & Co’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
27,616
+39
+0.1% +$18.3K 1.06% 32
2026
Q1
$10.9M Buy
27,577
+166
+0.6% +$75K 1.08% 34
2025
Q4
$12.9M Buy
27,411
+2,844
+12% +$1.26M 1.21% 27
2025
Q3
$12.1M Buy
24,567
+388
+2% +$219K 1.16% 34
2025
Q2
$12.4M Buy
24,179
+639
+3% +$298K 1.23% 28
2025
Q1
$10.1M Buy
23,540
+1,274
+6% +$619K 1.08% 37
2024
Q4
$10.8M Buy
22,266
+1,424
+7% +$744K 1.1% 36
2024
Q3
$10.6M Buy
+20,842
New +$11.2M 1.06% 39

Other funds holding SNPS

Jacobs & Co's SNPS Position: Q2 2026 in Review

Jacobs & Co increased its Synopsys (SNPS) stake by 0.14% in Q2 2026, buying an estimated $18.3K and bringing the position to 27,616 shares worth $12.3M. The position accounts for 1.06% of the portfolio, ranked #32.

Jacobs & Co first reported a position in SNPS in Q3 2024 and has held it in 8 quarters since. The position peaked at $12.9M in Q4 2025. 557 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Jacobs & Co held 27,616 shares of Synopsys worth $12.3M as of Q2 2026.
  • Jacobs & Co bought 39 Synopsys shares in Q2 2026, an estimated $18.3K.
  • Synopsys made up 1.06% of Jacobs & Co's portfolio in Q2 2026, its #32 holding.
  • Jacobs & Co first reported a position in Synopsys in Q3 2024 and has held it in 8 quarters since.
  • Jacobs & Co's Synopsys position peaked at $12.9M in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.